المصدر: Business Insider
وكالة أنباء
الأسهم
أهمية متوسطة
Starbucks is ending GLP-1 coverage for weight loss as employer costs climb
In October, Starbucks will stop covering GLP-1 drugs prescribed for weight loss for benefits-eligible employees. The move comes as GLP-1 drugs consume a growing share of employers' healthcare spending.
الرموز ذات الصلة
1
S
SBUX
SBUX
المصدر: Business Insider
زيارة المصدر